Patents for A61P 35 - Antineoplastic agents (221,099)
03/1995
03/09/1995CA2170508A1 Benzazole compounds for use in therapy
03/09/1995CA2170393A1 Cloning of a member of the serine-threonine-kinase family
03/09/1995CA2170390A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen
03/09/1995CA2169557A1 Treatment of human tumors by genetic transformation of human tumor cells
03/08/1995EP0641791A1 Novel benzothiophene derivative
03/08/1995EP0641785A1 Triazolylated tertiary amine compound or salt thereof
03/08/1995EP0641779A1 Novel 1-amidinopiperdines and 4-amidinomorpholines as aggregation inhibitions
03/08/1995EP0641767A1 Cytotoxic stilbene derivatives and pharmaceutical composition containing them
03/08/1995EP0641565A1 Contraceptive and menstrual cycle controlling drug having oncostatic properties
03/08/1995EP0641385A1 Development of dna probes and immunological reagents of human tumor associated antigens
03/08/1995EP0641359A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects
03/08/1995EP0641358A1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR
03/08/1995EP0641355A1 Steroid sulphatase inhibitors
03/08/1995EP0641342A1 Antiviral 2-ethyl-1h-imidazo(4,5-c)quinolin-4-amines
03/08/1995EP0641334A1 Novel taxane derivatives, their preparation and compositions containing same
03/08/1995EP0641327A1 Novel alpha-mannosidase inhibitors
03/08/1995EP0641211A1 INHIBITORS OF TESTOSTERONE 5$g(a)-REDUCTASE ACTIVITY
03/08/1995EP0641207A1 Enantiomeric cynemicin analogs, preparation and use thereof
03/08/1995EP0641193A1 Chemotherapeutic drug combinations
03/08/1995CN1099802A Tumor necrosis factor muteins
03/08/1995CN1099760A Cyclic adhesion inhibitors
03/08/1995CN1099759A 哌嗪衍生物 Piperazine derivatives
03/08/1995CN1099756A Tetrahydropyran derivatives
03/08/1995CN1099755A Cyclic derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
03/08/1995CN1099753A Derivatives of amino-ascorbic acid, processes for their preparation and use
03/08/1995CN1099612A Destroying or inhibiting growth of unwanted cells or tissues
03/08/1995CA2130864A1 Carboxamides
03/07/1995US5395850 Antitumor agents
03/07/1995US5395842 Inhibitors of sex steroids
03/07/1995CA1334671C Mitomycin phosphate derivatives
03/07/1995CA1334668C 13-alkyl-11beta-phenylgonanes
03/02/1995WO1995006120A1 Recombinant cells from the monocyte-macrophage cell line for gene therapy
03/02/1995WO1995006067A1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer
03/02/1995WO1995006065A1 Cytokines that bind the cell surface receptor hek
03/02/1995WO1995006054A1 Compound uch9
03/02/1995WO1995006040A1 Benzodiazepine compounds useful as antagonists of cck or of gastrine
03/02/1995WO1995006020A1 New diphenylhexene
03/02/1995WO1995005849A1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes
03/02/1995WO1995005847A1 Accessory factor function for interferon gamma and its receptor
03/02/1995WO1995005839A1 Nigella sativa as a medicinal treatment
03/02/1995WO1995005835A1 Gene therapy for solid tumors, papillomas and warts
03/02/1995WO1995005829A1 Therapeutic system for treating psoriasis
03/02/1995WO1995005821A1 Di- and tetra-hydrobenzo[f]quinolin-3-ones
03/02/1995WO1995005818A1 Photosensitizers
03/02/1995WO1995005750A1 Cell death regulator
03/02/1995WO1995003414A3 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor
03/02/1995DE4425481A1 Melanoma-inhibiting protein
03/02/1995CA2170159A1 Recombinant cells from the monocyte-macrophage cell ligne for gene therapy
03/02/1995CA2169956A1 Nigella sativa as a medicinal treatment
03/02/1995CA2169851A1 Cytokines that bind the cell surface receptor hek
03/02/1995CA2169849A1 Accessory factor function for interferon gamma and its receptor
03/02/1995CA2169750A1 Di- and tetra-hydrobenzo[f]quinolin-3-ones
03/02/1995CA2169089A1 Benzodiazepine derivatives
03/02/1995CA2168882A1 Therapeutic system for treating psoriasis
03/02/1995CA2147612A1 Compound uch9
03/01/1995EP0640614A2 Stereoselective process for preparing beta-anomer enriched 2-deoxy-2, 2-difluoro-d-ribofuranosyl-3, 5-hydroxy protected-1-alkyl and aryl sulfonate intermediates
03/01/1995EP0640613A1 OLIGOSIALYL-1,2-DIALKYL-Sn-GLYCEROL AND INTERMEDIATE FOR ITS SYNTHESIS
03/01/1995EP0640593A1 Substituted benzoylguanidines, process for their preparation, their use as medicine or in diagnostic and medicines containing them
03/01/1995EP0640346A1 Uses of sulphated sugars against inflammation
03/01/1995EP0640131A1 Genetically engineered antibodies
03/01/1995EP0640072A1 Substituted pyridines, their preparation and pharmaceutical use
03/01/1995EP0639982A1 Use of mmp inhibitors
03/01/1995EP0639981A1 Igf-1 analogs
03/01/1995EP0639979A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
03/01/1995EP0639977A1 Lipid-a analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities
03/01/1995EP0580753B1 Pyrimidine derivatives for enhancing antitumor activity
03/01/1995EP0406428B1 Peptide derivatives and their use
03/01/1995CN1099295A Application plaster for treatment of carcinosis pain
03/01/1995CN1099264A Cell differentiation inducer comprising acyclic polyisoprenoid
02/1995
02/28/1995US5393897 Isolation and structure of spongistatins 5,7,8 and 9
02/28/1995US5393896 Treating ground yew parts with water, separating aqueous solution, extracting with organic solvent, desolventizing, crystallizing, isolating
02/28/1995US5393889 Water soluble bis-dioxopiperazine derivatives
02/28/1995US5393760 Guanidine derivatives
02/28/1995US5393741 Anticarcinogenic agents
02/28/1995US5393737 Cytotoxic drug conjugates for treatment of neoplastic diseases
02/26/1995CA2130385A1 Inhibition of phosphatidylinositol 3-kinase with 17.beta.-hydroxywortmannin and analogs thereof
02/24/1995CA2130230A1 Sugar-modified interferon
02/23/1995WO1995005375A1 Indole derivatives as 5-alpha-reductase-1-inhibitors
02/23/1995WO1995005365A1 New bis-naphthalimides for the treatment of cancer
02/23/1995WO1995005359A1 Bicyclo (2.2.2) octane derivatives cholecystokinin and/or gastrin antagonists
02/23/1995DE4407538C1 Binding reagent for cell surface protein and effector cell
02/23/1995DE3991484C2 Pharmaceutical composition containing a specific inhibitor of the enzymatic conversion of protoporphyrinogen to protoporphyrin IX by protoporphyrinogen oxidase
02/23/1995CA2169059A1 New bis-naphthalimides for the treatment of cancer
02/23/1995CA2167156A1 Bicyclo(2.2.2) octane derivatives cholecystokinin and/or gastin antagonists
02/22/1995EP0639577A1 Phosphonooxymethyl or methylthiomethyl ethers of taxane derivatives as antitumor agents
02/22/1995EP0639575A1 Bicyclic heterocycles, medicaments comprising these compounds and processes for their production
02/22/1995EP0639573A1 Benzocondensed five membered heterocycles, process of their preparation, their use as drug, as diagnostic means and pharmaceuticals containing it
02/22/1995EP0639380A1 Cyclodextrin inclusion product of taxol, process for producing the same, and its use
02/22/1995EP0639225A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
02/22/1995EP0639186A1 Taxol derivatives
02/22/1995EP0639183A1 Nitrogen oxides of aza- and diaza-anthracenedione derivatives, their preparation and their use as antitumor agents
02/22/1995EP0639182A1 Quinoline derivatives
02/22/1995EP0639079A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
02/22/1995EP0639073A1 Biologically active ureido derivatives useful as antimetastatic agents
02/22/1995EP0526502B1 Phenolic amine depigmenting and antimelanoma agents
02/22/1995CN1099040A Linear adhesion inhibitor
02/22/1995CN1099032A Derivative of benzoxazine, preparation and pharmaceutical application of same
02/22/1995CN1098937A 998 Chinese medicinal pellet for treatment of primary carcinoma of liver
02/22/1995CN1098934A Anti-cancer compn. and prepn. thereof
02/21/1995US5391800 Protecting hydroxyl groups of sphingosine, deprotecting C1, phosphorylating, deprotecting C3; free of L-threo isomer